Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 103


The frequency and incremental cost of major complications among medicare beneficiaries receiving implantable cardioverter-defibrillators.

Reynolds MR, Cohen DJ, Kugelmass AD, Brown PP, Becker ER, Culler SD, Simon AW.

J Am Coll Cardiol. 2006 Jun 20;47(12):2493-7. Epub 2006 May 30.


Mortality and cost associated with cardiovascular implantable electronic device infections.

Sohail MR, Henrikson CA, Braid-Forbes MJ, Forbes KF, Lerner DJ.

Arch Intern Med. 2011 Nov 14;171(20):1821-8. doi: 10.1001/archinternmed.2011.441. Epub 2011 Sep 12.


Incremental Hospital Cost and Length-of-Stay Associated With Treating Adverse Events Among Medicare Beneficiaries Undergoing Lumbar Spinal Fusion During Fiscal Year 2013.

Culler SD, Jevsevar DS, Shea KG, McGuire KJ, Schlosser M, Wright KK, Simon AW.

Spine (Phila Pa 1976). 2016 Oct 15;41(20):1613-1620.


The additional hospital costs generated in the management of complications of pacemaker and defibrillator implantations.

Ferguson TB Jr, Ferguson CL, Crites K, Crimmins-Reda P.

J Thorac Cardiovasc Surg. 1996 Apr;111(4):742-51;discussion 751-2.


A review of the evidence on the effects and costs of implantable cardioverter defibrillator therapy in different patient groups, and modelling of cost-effectiveness and cost-utility for these groups in a UK context.

Buxton M, Caine N, Chase D, Connelly D, Grace A, Jackson C, Parkes J, Sharples L.

Health Technol Assess. 2006 Aug;10(27):iii-iv, ix-xi, 1-164. Review.


The frequency and cost of complications associated with coronary artery bypass grafting surgery: results from the United States Medicare program.

Brown PP, Kugelmass AD, Cohen DJ, Reynolds MR, Culler SD, Dee AD, Simon AW.

Ann Thorac Surg. 2008 Jun;85(6):1980-6. doi: 10.1016/j.athoracsur.2008.01.053.


Temporal trends in patient characteristics and outcomes among Medicare beneficiaries undergoing primary prevention implantable cardioverter-defibrillator placement in the United States, 2006-2010. Results from the National Cardiovascular Data Registry's Implantable Cardioverter-Defibrillator Registry.

Borne RT, Peterson PN, Greenlee R, Heidenreich PA, Wang Y, Curtis JP, Tzou WS, Varosy PD, Kremers MS, Masoudi FA.

Circulation. 2014 Sep 2;130(10):845-53. doi: 10.1161/CIRCULATIONAHA.114.008653. Epub 2014 Aug 5.


Incidence and Costs Related to Lead Damage Occurring Within the First Year After a Cardiac Implantable Electronic Device Replacement Procedure.

Nichols CI, Vose JG, Mittal S.

J Am Heart Assoc. 2016 Feb 12;5(2). pii: e002813. doi: 10.1161/JAHA.115.002813.


Cost-effectiveness of a microvolt T-wave alternans screening strategy for implantable cardioverter-defibrillator placement in the MADIT-II-eligible population.

Chan PS, Stein K, Chow T, Fendrick M, Bigger JT, Vijan S.

J Am Coll Cardiol. 2006 Jul 4;48(1):112-21. Epub 2006 Jun 9.


Cost-effectiveness of implantable cardioverter-defibrillators.

Sanders GD, Hlatky MA, Owens DK.

N Engl J Med. 2005 Oct 6;353(14):1471-80.


Safety of Outpatient Implantation of the Implantable Cardioverter-defibrillator.

Datino T, Miracle Blanco Á, Núñez García A, González-Torrecilla E, Atienza Fernández F, Arenal Maíz Á, Hernández-Hernández J, Ávila Alonso P, Eidelman G, Fernández-Avilés F.

Rev Esp Cardiol (Engl Ed). 2015 Jul;68(7):579-84. doi: 10.1016/j.rec.2014.07.038. Epub 2014 Nov 26.


Wearable cardioverter-defibrillator for prevention of sudden cardiac death after infected implantable cardioverter-defibrillator removal: A cost-effectiveness evaluation.

Healy CA, Carrillo RG.

Heart Rhythm. 2015 Jul;12(7):1565-73. doi: 10.1016/j.hrthm.2015.03.061. Epub 2015 Mar 31.


Utilization and outcomes of the implantable cardioverter defibrillator, 1987 to 1995.

Hlatky MA, Saynina O, McDonald KM, Garber AM, McClellan MB.

Am Heart J. 2002 Sep;144(3):397-403.


The cost effectiveness of implantable cardioverter-defibrillators: results from the Multicenter Automatic Defibrillator Implantation Trial (MADIT)-II.

Zwanziger J, Hall WJ, Dick AW, Zhao H, Mushlin AI, Hahn RM, Wang H, Andrews ML, Mooney C, Wang H, Moss AJ.

J Am Coll Cardiol. 2006 Jun 6;47(11):2310-8. Epub 2006 May 4.


Outcomes and costs of implantable cardioverter-defibrillators for primary prevention of sudden cardiac death among the elderly.

Groeneveld PW, Farmer SA, Suh JJ, Matta MA, Yang F.

Heart Rhythm. 2008 May;5(5):646-53. doi: 10.1016/j.hrthm.2008.01.038. Epub 2008 Jan 29.


Implantable cardioverter defibrillators for the treatment of arrhythmias and cardiac resynchronisation therapy for the treatment of heart failure: systematic review and economic evaluation.

Colquitt JL, Mendes D, Clegg AJ, Harris P, Cooper K, Picot J, Bryant J.

Health Technol Assess. 2014 Aug;18(56):1-560. doi: 10.3310/hta18560. Review.


The relation between patients' outcomes and the volume of cardioverter-defibrillator implantation procedures performed by physicians treating Medicare beneficiaries.

Al-Khatib SM, Lucas FL, Jollis JG, Malenka DJ, Wennberg DE.

J Am Coll Cardiol. 2005 Oct 18;46(8):1536-40. Epub 2005 Sep 23. Erratum in: J Am Coll Cardiol. 2005 Nov 15;46(10):1964.


Cost-effectiveness of primary prevention implantable cardioverter defibrillator treatment: data from a large clinical registry.

Thijssen J, van den Akker van Marle ME, Borleffs CJ, van Rees JB, de Bie MK, van der Velde ET, van Erven L, Schalij MJ.

Pacing Clin Electrophysiol. 2014 Jan;37(1):25-34. doi: 10.1111/pace.12238. Epub 2013 Sep 2.


Impact of the implantable cardioverter-defibrillator on rehospitalizations.

Valenti R, Schlåpfer J, Fromer M, Fischer A, Kappenberger L.

Eur Heart J. 1996 Oct;17(10):1565-71.


Supplemental Content

Support Center